 | Up a level |
Didden, EM; Ruffieux, Y; Hummel, N; Efthimiou, O; Reichenbach, S; Gsteiger, Sandro; Finckh, Axel; Fletcher, Christine; Salanti, G; Egger, Matthias; Work Package, IMI GetReal (2018). Prediction of Real-World Drug Effectiveness Prelaunch: Case Study in Rheumatoid Arthritis. Medical decision making, 38(6), pp. 719-729. Sage Publications 10.1177/0272989X18775975
Kilcher, Gablu Roman; Hummel, Noemi; Didden, Eva-Maria; Egger, Matthias; Reichenbach, Stephan (2018). Rheumatoid arthritis patients treated in trial and real world settings: comparison of randomized trials with registries. Rheumatology, 57(2), pp. 354-369. Oxford University Press 10.1093/rheumatology/kex394
Kilcher, G; Didden, E; Hummel, N; Egger, M (November 2015). Characteristics of Patients Starting Biologic Treatments for Rheumatoid Arthritis in The Real World: Systematic Review. Value in health, 18(7), A657-A658. Elsevier 10.1016/j.jval.2015.09.2379
